Author(s): Wong KK, Cahill JM, Frey KA, Avram AM
Abstract Share this page
Abstract RATIONALE AND OBJECTIVES: Hybrid single photon-emission computed tomographic (SPECT) and computed tomographic (CT) imaging for the investigation of neuroendocrine tumors allows the fusion of functional and anatomic information in a rapid and efficient method. The aim of this study was to assess the incremental diagnostic value of (111)In pentetreotide SPECT/CT imaging compared with traditional planar and SPECT imaging with respect to lesion localization and characterization and reader confidence. MATERIALS AND METHODS: Forty-nine patients (23 male, 26 female; mean age, 56.9 years; range, 14-88 years) who underwent (111)In pentetreotide planar, SPECT, and SPECT/CT imaging were eligible for this retrospective study, including patients with suspected or confirmed carcinoid tumors (n = 24), endocrine pancreatic tumors (n = 18), medullary thyroid cancer (n = 3), paragangliomas (n = 2), and multiple endocrine neoplasia type I (n = 2). Planar and SPECT images were reviewed by two blinded readers, followed by interpretation using additional SPECT/CT images in a subsequent session. A third reader provided consensus in cases with disagreements. RESULTS: In 55 of 89 lesions (61.8\%), (111)In pentetreotide SPECT/CT imaging improved lesion localization compared to planar and SPECT imaging; in 25 of 89 lesions (28.1\%), SPECT/CT imaging changed lesion classification. In 20 of 49 patients (40.8\%) for reader 1 and 14 of 49 patients (28.6\%) for reader 2, (111)In pentetreotide SPECT/CT imaging provided incremental diagnostic value, which was considered likely to affect patient management in twelve of 20 and seven of 14 patients, respectively. Increased reader confidence was found in 32 of 49 patients (65.3\%) for both readers with uniformly high confidence after SPECT/CT interpretation. CONCLUSIONS: Hybrid (111)In pentetreotide SPECT/CT imaging provides incremental diagnostic value and greater reader confidence over planar and SPECT imaging. This is achieved though superior lesion localization, the identification of physiologic activity, and additional anatomic information derived from the nondiagnostic CT portion of the study.
This article was published in Acad Radiol
and referenced in Journal of Cancer Science & Therapy